MeSH term
Frequency | Condition_Probility | Adult | 53 | 0.0 |
Female | 62 | 0.0 |
Humans | 119 | 0.0 |
Hypothyroidism/*blood | 2 | 7.0 |
Middle Aged | 38 | 0.0 |
Prolactin/*blood | 9 | 1.0 |
Protirelin/*pharmacology | 15 | 21.0 |
1-Phosphatidylinositol 3-Kinase/metabolism | 2 | 0.0 |
Animals | 32 | 0.0 |
Cell Line | 2 | 0.0 |
Genes, Reporter | 2 | 0.0 |
Male | 68 | 0.0 |
Recombinant Fusion Proteins/metabolism | 2 | 0.0 |
Research Support, Non-U.S. Gov't | 38 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 25 | 0.0 |
Receptors, Cell Surface/*metabolism | 4 | 0.0 |
Research Support, U.S. Gov't, Non-P.H.S. | 10 | 0.0 |
Adolescent | 22 | 0.0 |
Child | 7 | 0.0 |
Child, Preschool | 4 | 0.0 |
Immunohistochemistry | 3 | 0.0 |
Infant | 5 | 0.0 |
Protirelin/diagnostic use | 14 | 9.0 |
Somatotropin-Releasing Hormone/diagnostic use | 2 | 8.0 |
Thyroid Hormones/blood | 5 | 5.0 |
Thyrotropin/blood | 18 | 4.0 |
Protirelin/*biosynthesis | 2 | 100.0 |
Molecular Sequence Data | 2 | 0.0 |
Corticotropin/blood | 6 | 3.0 |
Hydrocortisone/blood | 6 | 1.0 |
Pituitary-Adrenal System/physiopathology | 4 | 16.0 |
Prolactin/blood | 10 | 1.0 |
Sensitivity and Specificity | 3 | 0.0 |
Thyroid Gland/physiopathology | 2 | 10.0 |
Thyroid Hormones/*blood | 6 | 10.0 |
Diarrhea/*microbiology | 3 | 23.0 |
English Abstract | 24 | 0.0 |
Enterobacteriaceae/*isolation & purification | 2 | 50.0 |
Japan | 2 | 0.0 |
Salmonella/isolation & purification | 2 | 66.0 |
*Travel | 2 | 7.0 |
*Bacterial Proteins | 2 | 1.0 |
*Genes, Bacterial | 4 | 5.0 |
Hemolysins/*genetics | 2 | 25.0 |
Hydrolysis | 3 | 0.0 |
Urea/*metabolism | 2 | 9.0 |
Aged | 20 | 0.0 |
Chromatography, High Pressure Liquid | 5 | 0.0 |
Follicle Stimulating Hormone/blood | 11 | 2.0 |
Gonadorelin/diagnostic use | 4 | 6.0 |
Luteinizing Hormone/blood | 11 | 2.0 |
Pyrrolidonecarboxylic Acid/analogs & derivatives | 6 | 24.0 |
Radioimmunoassay | 8 | 0.0 |
Reference Values | 4 | 0.0 |
Disease Models, Animal | 4 | 0.0 |
Dogs | 2 | 0.0 |
Thyroxine/blood | 13 | 5.0 |
Triiodothyronine/blood | 10 | 4.0 |
Body Weight | 2 | 0.0 |
Chronic Disease | 2 | 0.0 |
Hydrogen-Ion Concentration | 2 | 0.0 |
Protirelin/pharmacology | 7 | 6.0 |
Thyroid Gland/*physiopathology | 3 | 11.0 |
Amino Acid Sequence | 2 | 0.0 |
Half-Life | 2 | 0.0 |
Hippocampus/metabolism | 2 | 2.0 |
Rats | 17 | 0.0 |
Base Sequence | 2 | 0.0 |
Phenotype | 2 | 0.0 |
Comparative Study | 10 | 0.0 |
Pituitary Hormone-Releasing Hormones/*pharmacology | 3 | 23.0 |
Somatotropin-Releasing Hormone/pharmacology | 2 | 4.0 |
Aged, 80 and over | 4 | 0.0 |
Drug Synergism | 3 | 0.0 |
Prolactin/blood/secretion | 2 | 8.0 |
Protirelin/*therapeutic use | 2 | 33.0 |
Stimulation, Chemical | 2 | 0.0 |
Thyrotropin/blood/secretion | 2 | 22.0 |
Serotyping | 2 | 0.0 |
Vibrio parahaemolyticus/*genetics | 2 | 100.0 |
Diagnosis, Differential | 2 | 0.0 |
Pregnancy | 9 | 0.0 |
Protirelin/blood | 2 | 20.0 |
Thyroid Function Tests | 6 | 7.0 |
Protirelin/*diagnostic use | 11 | 13.0 |
Thyrotropin/*blood | 13 | 10.0 |
Drug Tolerance | 2 | 1.0 |
Time Factors | 5 | 0.0 |
Depressive Disorder/*blood | 2 | 25.0 |
Japan/epidemiology | 2 | 0.0 |
*Vibrio parahaemolyticus | 2 | 66.0 |
Enzyme-Linked Immunosorbent Assay | 2 | 0.0 |
Cattle | 2 | 0.0 |
Mice | 2 | 0.0 |
Dose-Response Relationship, Drug | 5 | 0.0 |
Prolactin/*secretion | 5 | 2.0 |
Chromatography, Ion Exchange | 2 | 0.0 |
Chromatography, Gel | 3 | 0.0 |
Spectrum Analysis, Mass | 2 | 0.0 |
Growth Hormone/blood | 10 | 4.0 |
Somatotropin-Releasing Hormone/blood | 2 | 28.0 |
Thyrotropin/blood/*secretion | 2 | 9.0 |
1-Methyl-3-isobutylxanthine/pharmacology | 2 | 2.0 |
8-Bromo Cyclic Adenosine Monophosphate/pharmacology | 3 | 3.0 |
Cells, Cultured | 4 | 0.0 |
Chickens/*physiology | 2 | 40.0 |
Drug Interactions | 3 | 0.0 |
Forskolin/pharmacology | 2 | 0.0 |
Growth Hormone/*secretion | 3 | 2.0 |
Dexamethasone/pharmacology | 2 | 0.0 |
Protirelin/*metabolism | 2 | 40.0 |
Structure-Activity Relationship | 4 | 0.0 |
Hypothalamo-Hypophyseal System/physiopathology | 2 | 5.0 |
Somatotropin-Releasing Hormone/*pharmacology | 4 | 4.0 |
Pituitary Hormones, Anterior/*blood | 3 | 9.0 |
Perfusion | 4 | 1.0 |
Chickens | 2 | 0.0 |
Cycloheximide/pharmacology | 2 | 0.0 |
Cell Membrane/metabolism | 2 | 0.0 |
Age Factors | 3 | 0.0 |
Pituitary Function Tests | 2 | 6.0 |
Sex Factors | 2 | 0.0 |
Peptides, Cyclic/*biosynthesis | 2 | 100.0 |
Piperazines/*biosynthesis | 2 | 100.0 |
Tissue Distribution | 4 | 0.0 |
Growth Hormone/blood/*secretion | 2 | 2.0 |
Kinetics | 7 | 0.0 |
*Energy Intake | 2 | 5.0 |
Triiodothyronine, Reverse/blood | 2 | 7.0 |
Gonadorelin/*pharmacology | 3 | 8.0 |
Protirelin/*analysis | 2 | 66.0 |
Depression, Chemical | 2 | 1.0 |
Pituitary Gland/drug effects/*secretion | 3 | 25.0 |
Protirelin/physiology | 3 | 37.0 |
Somatostatin/physiology | 2 | 9.0 |
Rats, Inbred Strains | 4 | 0.0 |
Protein Binding | 2 | 0.0 |
Receptors, Somatostatin | 2 | 13.0 |
Somatostatin/analogs & derivatives/metabolism | 2 | 40.0 |
Thyrotropin/*secretion | 2 | 5.0 |
Hyperthyroidism/blood/*diagnosis | 2 | 66.0 |
Radioimmunoassay/methods | 3 | 1.0 |
Protirelin/*analogs & derivatives/*pharmacology | 2 | 100.0 |
Stereotyped Behavior/*drug effects | 2 | 28.0 |
Bromocriptine/*therapeutic use | 2 | 2.0 |
Amitriptyline/pharmacology | 2 | 100.0 |
Alprostadil | 2 | 15.0 |
Benzamides/pharmacology | 2 | 9.0 |
Dopamine/*pharmacology | 2 | 7.0 |
Pituitary Neoplasms/*secretion | 3 | 6.0 |
Prostaglandins E/*pharmacology | 2 | 14.0 |
Receptors, Dopamine/*drug effects | 2 | 7.0 |
Sulpiride/pharmacology | 2 | 11.0 |
Theophylline/*pharmacology | 2 | 22.0 |
Gynecomastia/*blood | 2 | 100.0 |
Infant, Newborn | 2 | 0.0 |
Receptors, Dopamine/drug effects | 2 | 7.0 |
Protirelin/*blood | 2 | 33.0 |
Gonadorelin/pharmacology | 2 | 4.0 |
*Morphine Dependence | 2 | 66.0 |
Shivering/*drug effects | 2 | 100.0 |
Biological Assay | 2 | 0.0 |
Cross Reactions | 2 | 0.0 |
Placenta/*analysis | 2 | 7.0 |
Goiter/*blood/metabolism | 2 | 100.0 |
Iodine/blood/metabolism | 2 | 100.0 |
Protirelin/*blood/pharmacology | 2 | 100.0 |
Thyroid Gland/drug effects/metabolism | 2 | 25.0 |
